Amoy Diagnostics Co., Ltd.

Shenzhen Stock Exchange 300685.SZ

Amoy Diagnostics Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2023: USD 0.09

Amoy Diagnostics Co., Ltd. Free Cash Flow Per Share is USD 0.09 for the year ending December 31, 2023, a 246.50% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Amoy Diagnostics Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2022 was USD 0.03, a -30.06% change year over year.
Amoy Diagnostics Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2021 was USD 0.04, a -40.90% change year over year.
Amoy Diagnostics Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2020 was USD 0.06, a -11.22% change year over year.
Amoy Diagnostics Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2019 was USD 0.07, a 248.38% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

Shenzhen Stock Exchange: 300685.SZ

Amoy Diagnostics Co., Ltd.

CEO	Ms. Ying Chen
IPO Date	Aug. 3, 2017
Location	China
Headquarters	39 Dingshan Road
Employees	1,119
Sector	Healthcare
Industries Biotechnology

Description

Amoy Diagnostics Co., Ltd., a diagnostic company, focuses on molecular diagnostics for oncology precision medicine in China and internationally. The company offers NGS, real-time PCR, FISH, and extraction assays. Amoy Diagnostics Co., Ltd. was founded in 2008 and is based in Xiamen, China.

Key trends

Past 5 years